| Title: |
Post-infarction ventricular septal defect: percutaneous or surgical management in the UK national registry |
| Authors: |
Giblett, Joel P; Matetic, Andrija; Jenkins, David; Ng, Choo Y; Venuraju, Shreenidhi; MacCarthy, Tobias; Vibhishanan, Jonathan; O’Neill, John P; Kirmani, Bilal H; Pullan, D Mark; Stables, Rod H; Andrews, Jack; Buttinger, Nicolas; Kim, Wan Cheol; Kanyal, Ritesh; Butler, Megan A; Butler, Robert; George, Sudhakar; Khurana, Ayush; Crossland, David S; Marczak, Jakub; Smith, William H T; Thomson, John D R; Bentham, James R; Clapp, Brian R; Buch, Mamta; Hayes, Nicholas; Byrne, Jonathan; MacCarthy, Philip; Aggarwal, Suneil K; Shapiro, Leonard M; Turner, Mark S; de Giovanni, Joe; Northridge, David B; Hildick-Smith, David; Mamas, Mamas A; Calvert, Patrick A |
| Contributors: |
National Institute for Health Research North-West Coast; Research Scholar Programme. |
| Source: |
European Heart Journal ; volume 43, issue 48, page 5020-5032 ; ISSN 0195-668X 1522-9645 |
| Publisher Information: |
Oxford University Press (OUP) |
| Publication Year: |
2022 |
| Description: |
Aims Post-infarction ventricular septal defect (PIVSD) is a mechanical complication of acute myocardial infarction (AMI) with a poor prognosis. Surgical repair is the mainstay of treatment, although percutaneous closure is increasingly undertaken. Methods and resuts Patients treated with surgical or percutaneous repair of PIVSD (2010–2021) were identified at 16 UK centres. Case note review was undertaken. The primary outcome was long-term mortality. Patient groups were allocated based upon initial management (percutaneous or surgical). Three-hundred sixty-two patients received 416 procedures (131 percutaneous, 231 surgery). 16.1% of percutaneous patients subsequently had surgery. 7.8% of surgical patients subsequently had percutaneous treatment. Times from AMI to treatment were similar [percutaneous 9 (6–14) vs. surgical 9 (4–22) days, P = 0.18]. Surgical patients were more likely to have cardiogenic shock (62.8% vs. 51.9%, P = 0.044). Percutaneous patients were substantially older [72 (64–77) vs. 67 (61–73) years, P < 0.001] and more likely to be discussed in a heart team setting. There was no difference in long-term mortality between patients (61.1% vs. 53.7%, P = 0.17). In-hospital mortality was lower in the surgical group (55.0% vs. 44.2%, P = 0.048) with no difference in mortality after hospital discharge (P = 0.65). Cardiogenic shock [adjusted hazard ratio (aHR) 1.97 (95% confidence interval 1.37–2.84), P < 0.001), percutaneous approach [aHR 1.44 (1.01–2.05), P = 0.042], and number of vessels with coronary artery disease [aHR 1.22 (1.01–1.47), P = 0.043] were independently associated with long-term mortality. Conclusion Surgical and percutaneous repair are viable options for management of PIVSD. There was no difference in post-discharge long-term mortality between patients, although in-hospital mortality was lower for surgery. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1093/eurheartj/ehac511 |
| Availability: |
https://doi.org/10.1093/eurheartj/ehac511; https://academic.oup.com/eurheartj/article-pdf/43/48/5020/48306052/ehac511.pdf |
| Rights: |
https://academic.oup.com/pages/standard-publication-reuse-rights |
| Accession Number: |
edsbas.3BAC432B |
| Database: |
BASE |